Skip to content

Evaluation of the Nella Women's Care Line

An Evaluation of the Safety and TechnIcal Feasibility Of the NelLa Women's Care Line for Female Gynecological ExaminaTions and Procedures (VIOLET)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03123367
Enrollment
154
Registered
2017-04-21
Start date
2017-03-06
Completion date
2017-06-27
Last updated
2018-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GYN Disorders

Brief summary

Evaluation of the Nella Women's Care Line

Detailed description

The Nella Women's Care Line is being studied in women undergoing a gynecological exam and other gynecological procedures that require visibility and access to the cervix.

Interventions

DEVICEGroup 1: Nella VuSleeve

Sleeve

DEVICEGroup 2: Nella NuSpec

Speculum

DEVICEGroup 3: NellaSpec

Speculum

DEVICEGroup 4: Nella Insert

Sleeve

Sponsors

Ceek Enterprises
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

General inclusion criteria (applies to all study groups): * Subject is female * Subject is 18 - 65 years of age, inclusive, at the time of consent * Subject is undergoing a gynecological examination (as defined above) as part of their regular clinical care * Subject has undergone one or more prior gynecological exams * Subject is willing and able to provide written informed consent * Subject is able and willing to perform the functions required by the study protocol General

Exclusion criteria

(applies to all study groups): * Subject has undergone hysterectomy * Subject has a known history of allergies to latex or plastics * Subject is pregnant * Subject is post-partum (≤ 12 weeks) * Subject has had an induced or spontaneous abortion in the prior 12 weeks * Subject has an active gynecologic complaint that, in the opinion of the clinician, would confound study results * Subject has dyspareunia * Subject has a known history of vulvodynia such as vulvular vestibular syndrome * Subject has a known history of vaginismus * Subject has a planned surgical procedure along with the gynecological exam * Subject is under incarceration * Subject is unable to provide written informed consent Device specific inclusion criteria: In addition to the general inclusion, the subject must meet all device specific criteria associated with their assignment group. Below are device-specific criteria. There is no device-specific exclusion criterion. Nella VuSleeve (Group 1) inclusion: • Subject has a BMI ≥ 30 and/or 3 or more vaginal births NellaSpec (Group 2), Nella NuSpec (Group 3), and Nella Insert (Group 4) inclusion: • Subject has a BMI \< 35

Design outcomes

Primary

MeasureTime frameDescription
Technical FeasibilityDay of Exam or ProcedureCervical visualization and access

Secondary

MeasureTime frameDescription
SafetyDay of Exam or ProcedureNumber of Adverse Events (AEs)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026